Stock listing

NASDAQ:KALV KalVista Pharmaceuticals, Inc. Stock

Home listing (NASDAQ) of KalVista Pharmaceuticals, Inc.

Follow KalVista Pharmaceuticals, Inc. into a list and get an email when it puts out news.

KalVista Pharmaceuticals, Inc. logo
Ticker
NASDAQ:KALV
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • KalVista Pharmaceuticals (NASDAQ:KALV) Q3 2025 Earnings Call

    Tue, Nov 11, 2025 · 8:30 AM ET

    Watch Transcript
  • KalVista Pharmaceuticals (NASDAQ:KALV) Q2 2025 Earnings Call

    Thu, Sep 11, 2025 · 8:30 AM ET

    Watch Transcript

Latest news

All KalVista Pharmaceuticals, Inc. news

Financings

  • Convertible notes

    Nov 10, 2025

    Closed: US$144M raised

    Use of proceeds: Continue advancing the global launch strategy for EKTERLY and building long-term growth

    Made bigger Sep 24, 2025 · Closed Nov 10, 2025

  • Convertible Senior Notes due 2031

    Sep 24, 2025

    Announced: US$110M

    Use of proceeds: Working capital and general corporate purposes, including the commercialization of EKTERLY; possibly investments in or acquisitions of other companies or products

    Announced Sep 24, 2025

Read by 6ix AI from the company's releases

Decks

KalVista Pharmaceuticals, Inc. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
15 in the last 12 months · 164 in all · newest Nov 12, 2026 · oldest 2019
Calls
2 calls with a replay · 2 with a transcript · latest Nov 11, 2025
Decks
17 decks · latest October 2026

Where KalVista Pharmaceuticals, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:KALV · Home listing · This pageNASDAQUnited StatesUSD
gettex:4XC1gettexGermanyEUR
LS Exchange:A2DG49LS ExchangeGermanyEUR
Tradegate:4XC1TradegateGermanyEUR
BOATS:KALVBOATSUnited StatesUSD
Lang & Schwarz:A2DG49Lang & SchwarzGermanyEUR
Frankfurt:4XC1FrankfurtGermanyEUR
Munich:4XC1MunichGermanyEUR
Dusseldorf:4XC1DusseldorfGermanyEUR
Hamburg:4XC1HamburgGermanyEUR
Stuttgart:4XC1StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about KalVista Pharmaceuticals, Inc.